Overview of adult immunization in Italy: Successes, lessons learned and the way forward

Hum Vaccin Immunother. 2024 Dec 31;20(1):2411821. doi: 10.1080/21645515.2024.2411821. Epub 2024 Oct 21.

Abstract

The exchange of knowledge and best practices in adult immunization are essential to improve vaccination strategies across the European region. Italy has made groundbreaking progress in the field, being one of the first countries to propose a life-course vaccination schedule, broadening the traditional focus on childhood immunization to include adults. All vaccines included in Italy's vaccination schedule are free of charge. Moreover, the country's National Immunization Plan sets clear coverage targets, immunization priorities, and actions to reduce disparities. However, the fragmentation of its National Health System following the constitutional reform of 2001 has led to an increased complexity and regional inequalities regarding immunization. Other challenges the country faces include growing vaccine hesitancy, data gaps and underserved populations. This review describes Italy's adult immunization system, from policy to implementation. The successes, challenges and lessons learned were shared during the first Adult Immunization Board country meeting in Italy, where local experts, healthcare providers, public health representatives, and policymakers engaged in collaborative discussions and shared insights through case studies and presentations (December 2023). These insights are reviewed and discussed in this manuscript.

Keywords: Vaccination; epidemiology; health policy; pharmacovigilance; prevention and control; public health; vaccine hesitancy.

Publication types

  • Review

MeSH terms

  • Adult
  • Health Policy
  • Humans
  • Immunization Programs* / organization & administration
  • Immunization Schedule
  • Italy
  • Vaccination
  • Vaccination Coverage
  • Vaccination Hesitancy
  • Vaccines / administration & dosage

Substances

  • Vaccines

Grants and funding

The AIB is supported by an unrestricted grant from Vaccines Europe (www.vaccineseurope.eu) and applies the ethical rules of its hosting universities, the University of Antwerp and the University of Florence, to guarantee strict operational and scientific independence throughout its activities.